Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.

about

Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.

Item

http://www.wikidata.org/entity/Q47445376

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Validating the use of brain vo ...... ally relevant atrophy in RRMS.

@en

Validating the use of brain vo ...... ally relevant atrophy in RRMS.

@nl

type

Item

label

Validating the use of brain vo ...... ally relevant atrophy in RRMS.

@en

Validating the use of brain vo ...... ally relevant atrophy in RRMS.

@nl

prefLabel

Validating the use of brain vo ...... ally relevant atrophy in RRMS.

@en

Validating the use of brain vo ...... ally relevant atrophy in RRMS.

@nl

P1476

Validating the use of brain vo ...... cally relevant atrophy in RRMS

@en

P2093

Joshua R Steinerman

http://www.w3.org/2001/XMLSchema#string

Nicola De Stefano

http://www.w3.org/2001/XMLSchema#string

Volker Knappertz

http://www.w3.org/2001/XMLSchema#string

P2860

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Clinical relevance of brain volume measures in multiple sclerosis.

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis.

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.

Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.

Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis

Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures

Brain atrophy and lesion load predict long term disability in multiple sclerosis.

P304

217-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458517743804

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M P Sormani

Francesca Bovis

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29154721

http://www.w3.org/2001/XMLSchema#string